Biotechnologies to tackle the challenge of neoantigen identification.

Arnaud, Marion; Duchamp, Margaux; Bobisse, Sara; Renaud, Philippe; Coukos, George; Harari, Alexandre

Arnaud, Marion; Duchamp, Margaux; Bobisse, Sara; Renaud, Philippe; Coukos, George; Harari, Alexandre.

Afiliação

Arnaud M; Department of oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), CH-1005, Switzerland.
Duchamp M; Laboratory of microsystems 4 (LMIS4), EPFL, Lausanne, CH-1015, Switzerland.
Bobisse S; Department of oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), CH-1005, Switzerland.
Renaud P; Laboratory of microsystems 4 (LMIS4), EPFL, Lausanne, CH-1015, Switzerland.
Coukos G; Department of oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), CH-1005, Switzerland.
Harari A; Department of oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), CH-1005, Switzerland. Electronic address: alexandre.harari@chuv.ch.

Curr Opin Biotechnol ; 65: 52-59, 2020 10.

Article em En | MEDLINE | ID: mdl-31927304

Assuntos

Antígenos de Neoplasias; Neoplasias; Biotecnologia; Humanos; Imunoterapia; Neoplasias/diagnóstico; Neoplasias/terapia; Estudos Prospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Neoplasias / Neoplasias Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Curr Opin Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google